These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33191195)

  • 21. Impact of the 2013 Cholesterol Guideline on Patterns of Lipid-Lowering Treatment in Patients with Atherosclerotic Cardiovascular Disease or Diabetes After 1 Year.
    Tran JN; Kao TC; Caglar T; Stockl KM; Spertus JA; Lew HC; Solow BK; Chan PS
    J Manag Care Spec Pharm; 2016 Aug; 22(8):901-8. PubMed ID: 27459652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statins, Mortality, and Major Adverse Cardiovascular Events Among US Veterans With Chronic Kidney Disease.
    Barayev O; Hawley CE; Wellman H; Gerlovin H; Hsu W; Paik JM; Mandel EI; Liu CK; Djoussé L; Gaziano JM; Gagnon DR; Orkaby AR
    JAMA Netw Open; 2023 Dec; 6(12):e2346373. PubMed ID: 38055276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011-2012.
    Wong ND; Young D; Zhao Y; Nguyen H; Caballes J; Khan I; Sanchez RJ
    J Clin Lipidol; 2016; 10(5):1109-18. PubMed ID: 27678427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and significance of risk enhancing biomarkers in the United States population at intermediate risk for atherosclerotic disease.
    Vega GL; Wang J; Grundy SM
    J Clin Lipidol; 2022; 16(1):66-74. PubMed ID: 34922882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Residual Hypertriglyceridemia and Estimated Atherosclerotic Cardiovascular Disease Risk by Statin Use in U.S. Adults With Diabetes: National Health and Nutrition Examination Survey 2007-2014.
    Fan W; Philip S; Granowitz C; Toth PP; Wong ND
    Diabetes Care; 2019 Dec; 42(12):2307-2314. PubMed ID: 31575639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016.
    Yao X; Shah ND; Gersh BJ; Lopez-Jimenez F; Noseworthy PA
    JAMA Netw Open; 2020 Nov; 3(11):e2025505. PubMed ID: 33216139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statin Trials, Cardiovascular Events, and Coronary Artery Calcification: Implications for a Trial-Based Approach to Statin Therapy in MESA.
    Mortensen MB; Falk E; Li D; Nasir K; Blaha MJ; Sandfort V; Rodriguez CJ; Ouyang P; Budoff M
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 1):221-230. PubMed ID: 28624395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low statin use in nondialysis-dependent chronic kidney disease in the absence of clinical atherosclerotic cardiovascular disease or diabetes.
    Markossian TW; Kramer HJ; Burge NJ; Pacold IV; Leehey DJ; Huo Z; Schneider J; Ling B; Stroupe KT
    Clin Kidney J; 2019 Aug; 12(4):530-537. PubMed ID: 31384445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dyslipidaemia in patients with chronic kidney disease - a neglected cardiovascular risk factor.
    Essop MR; Seedat F; Raal FJ
    S Afr Med J; 2023 Nov; 113(11):35-40. PubMed ID: 38525632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
    Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
    JAMA Cardiol; 2017 Jan; 2(1):47-54. PubMed ID: 27829091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.
    Tuttle KR; Dworkin LD; Henrich W; Greco BA; Steffes M; Tobe S; Shapiro JI; Jamerson K; Lyass A; Pencina K; Massaro JM; D'Agostino RB; Cutlip DE; Murphy TP; Cooper CJ
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1180-1188. PubMed ID: 27225988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study.
    Yang Q; Zhong Y; Gillespie C; Merritt R; Bowman B; George MG; Flanders WD
    BMJ Open; 2017 Jan; 7(1):e011684. PubMed ID: 28119384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People: The BioImage Study.
    Mortensen MB; Fuster V; Muntendam P; Mehran R; Baber U; Sartori S; Falk E
    J Am Coll Cardiol; 2016 Aug; 68(9):881-91. PubMed ID: 27561760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrasting Cholesterol Management Guidelines for Adults with CKD.
    Colantonio LD; Baber U; Banach M; Tanner RM; Warnock DG; Gutiérrez OM; Safford MM; Wanner C; Howard G; Muntner P
    J Am Soc Nephrol; 2015 May; 26(5):1173-80. PubMed ID: 25395432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2013 ACC/AHA Cholesterol Guideline and Implications for Healthy People 2020 Cardiovascular Disease Prevention Goals.
    Egan BM; Li J; White K; Fleming DO; Connell K; Hernandez GT; Jones DW; Ferdinand KC; Sinopoli A
    J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27543306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Statins on Renal Outcome in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis.
    Sanguankeo A; Upala S; Cheungpasitporn W; Ungprasert P; Knight EL
    PLoS One; 2015; 10(7):e0132970. PubMed ID: 26151753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Projections of incident atherosclerotic cardiovascular disease and incident type 2 diabetes across evolving statin treatment guidelines and recommendations: A modelling study.
    Engeda JC; Lhachimi SK; Rosamond WD; Lund JL; Keyserling TC; Safford MM; Colantonio LD; Muntner P; Avery CL
    PLoS Med; 2020 Aug; 17(8):e1003280. PubMed ID: 32845900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease.
    Chan J; Rajalingam T; Fossella J; Zhou H; Eisenberg N; Roche-Nagle G
    Ann Vasc Surg; 2020 Nov; 69():197-205. PubMed ID: 32554202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Residual atherosclerotic cardiovascular disease risk in statin-treated adults: The Multi-Ethnic Study of Atherosclerosis.
    Wong ND; Zhao Y; Quek RGW; Blumenthal RS; Budoff MJ; Cushman M; Garg P; Sandfort V; Tsai M; Lopez JAG
    J Clin Lipidol; 2017; 11(5):1223-1233. PubMed ID: 28754224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Qureshi WT; Kaplan RC; Swett K; Burke G; Daviglus M; Jung M; Talavera GA; Chirinos DA; Reina SA; Davis S; Rodriguez CJ
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28495699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.